Correlation Between Veracyte and Xenon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Veracyte and Xenon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Xenon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Xenon Pharmaceuticals, you can compare the effects of market volatilities on Veracyte and Xenon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Xenon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Xenon Pharmaceuticals.
Diversification Opportunities for Veracyte and Xenon Pharmaceuticals
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Veracyte and Xenon is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Xenon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xenon Pharmaceuticals and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Xenon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xenon Pharmaceuticals has no effect on the direction of Veracyte i.e., Veracyte and Xenon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Veracyte and Xenon Pharmaceuticals
Given the investment horizon of 90 days Veracyte is expected to under-perform the Xenon Pharmaceuticals. In addition to that, Veracyte is 1.29 times more volatile than Xenon Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Xenon Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 3,863 in Xenon Pharmaceuticals on October 21, 2024 and sell it today you would lose (11.00) from holding Xenon Pharmaceuticals or give up 0.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Xenon Pharmaceuticals
Performance |
| Timeline |
| Veracyte |
| Xenon Pharmaceuticals |
Veracyte and Xenon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Xenon Pharmaceuticals
The main advantage of trading using opposite Veracyte and Xenon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Xenon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenon Pharmaceuticals will offset losses from the drop in Xenon Pharmaceuticals' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Xenon Pharmaceuticals vs. Nuvalent | Xenon Pharmaceuticals vs. Arcellx | Xenon Pharmaceuticals vs. Vaxcyte | Xenon Pharmaceuticals vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |